Stock Analiz

Celldex Therapeutics, Inc. (CLDX) stock forecast and price target

Price $28.83 · data as of November 13, 2026

12-month price target

Average target$64.00
Upside / downside+122.0%
Analysts14
ConsensusStrong buy
Low $29.00Average $64.00High $100.00

Gold marker: average target · white marker: today’s price ($28.83)

Analyst ratings

Strong buy 2Buy 12Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.05−3.8%$1M
Next fiscal year
ends December 31, 2027
$-4.21−4.0%$7M
Next quarter
ends December 31, 2026
$-1.00+17.7%$2M
Quarter after
ends March 31, 2027
$-0.97+17.5%$250000

Consensus of the analysts covering Celldex Therapeutics, updated daily. In the last 30 days 3 estimates were raised and 1 lowered.

Frequently asked questions

What is the Celldex Therapeutics stock price target?

The average 12-month target from 14 analysts is $64.00, 122.0% above the current price of $28.83 Targets range from $29.00 to $100.00.

Is Celldex Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 12 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Celldex Therapeutics expected to earn?

Analysts expect EPS of $-4.05 for the fiscal year ending December 31, 2026 and $-4.21 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.